v3.25.2
Schedule of operating segments (Details) - USD ($)
 11 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2025
Mar. 31, 2024
IfrsStatementLineItems [Line Items]      
Loss before tax $ (18,503)    
Income tax credit    
Loss for the financial year (18,503)    
Segment liabilities 18,503 $ 18,503  
Alps Life Science Inc [Member]      
IfrsStatementLineItems [Line Items]      
Loss from operations   (2,480,893) $ (2,355,731)
Finance costs   (48,283) (42,844)
Loss before tax   (2,529,176) (2,398,575)
Income tax credit   (95,562) 7,414
Loss for the financial year   (2,624,738) (2,391,161)
Segment assets 7,133,637 7,133,637 6,700,933
Segment liabilities 8,249,553 8,249,553 5,249,941
Amortisation of intangible assets   163,093 44,807
Amortisation of right-of-use assets   500,144 403,019
Additional of property, plant and equipment   83,772 221,317
Depreciation of property, plant and equipment   465,287 455,613
Property, plant and equipment written off   14,083
Alps Life Science Inc [Member] | Elimination of intersegment amounts [member]      
IfrsStatementLineItems [Line Items]      
Total revenue   (736,233) (652,366)
Loss from operations  
Finance costs  
Loss before tax  
Income tax credit  
Loss for the financial year  
Segment assets (8,892,075) (8,892,075) (6,543,765)
Segment liabilities (8,666,225) (8,666,225) (6,383,376)
Amortisation of intangible assets  
Amortisation of right-of-use assets  
Additional of property, plant and equipment  
Depreciation of property, plant and equipment  
Property, plant and equipment written off    
Alps Life Science Inc [Member] | Operating segments [member]      
IfrsStatementLineItems [Line Items]      
Total revenue   3,371,037 2,403,552
Loss from operations   (2,480,893) (2,355,731)
Finance costs   (48,283) (42,844)
Loss before tax   (2,529,176) (2,398,575)
Income tax credit   (95,562) 7,414
Loss for the financial year   (2,624,738) (2,391,161)
Segment assets 7,133,637 7,133,637 6,700,933
Segment liabilities 8,249,553 8,249,553 5,249,941
Amortisation of intangible assets   163,093 44,807
Amortisation of right-of-use assets   500,144 403,019
Additional of property, plant and equipment   83,772 221,317
Depreciation of property, plant and equipment   465,287 455,613
Property, plant and equipment written off     14,083
Medical and wellness segments [member] | Alps Life Science Inc [Member]      
IfrsStatementLineItems [Line Items]      
Total revenue   3,396,367 2,577,255
Loss from operations   32,555 (381,848)
Finance costs   (22,825) (6,944)
Loss before tax   9,730 (388,792)
Income tax credit   (93,487) 7,414
Loss for the financial year   (83,757) (381,378)
Segment assets 2,507,576 2,507,576 1,888,659
Segment liabilities 3,432,954 3,432,954 2,676,331
Amortisation of intangible assets   31
Amortisation of right-of-use assets   199,618 141,762
Additional of property, plant and equipment   35,675 75,773
Depreciation of property, plant and equipment   58,580 67,906
Property, plant and equipment written off     14,083
Life science segments [member] | Alps Life Science Inc [Member]      
IfrsStatementLineItems [Line Items]      
Total revenue   613,490 393,419
Loss from operations   (977,212) (1,130,176)
Finance costs   (6,253) (12,240)
Loss before tax   (983,465) (1,142,416)
Income tax credit   (2,075)
Loss for the financial year   (985,540) (1,142,416)
Segment assets 3,628,762 3,628,762 2,893,474
Segment liabilities 7,084,309 7,084,309 5,194,755
Amortisation of intangible assets  
Amortisation of right-of-use assets   121,530 117,110
Additional of property, plant and equipment   41,989 42,013
Depreciation of property, plant and equipment   386,024 370,197
Property, plant and equipment written off    
All other segments [member] | Alps Life Science Inc [Member]      
IfrsStatementLineItems [Line Items]      
Total revenue   97,413 85,244
Loss from operations   (1,536,236) (843,707)
Finance costs   (19,205) (23,660)
Loss before tax   (1,555,441) (867,367)
Income tax credit  
Loss for the financial year   (1,555,441) (867,367)
Segment assets 9,889,374 9,889,374 8,462,565
Segment liabilities $ 6,398,515 6,398,515 3,762,231
Amortisation of intangible assets   163,093 44,776
Amortisation of right-of-use assets   178,996 144,147
Additional of property, plant and equipment   6,108 103,531
Depreciation of property, plant and equipment   20,683 17,510
Property, plant and equipment written off    
External sales [member] | Alps Life Science Inc [Member] | Elimination of intersegment amounts [member]      
IfrsStatementLineItems [Line Items]      
Total revenue  
External sales [member] | Alps Life Science Inc [Member] | Operating segments [member]      
IfrsStatementLineItems [Line Items]      
Total revenue   3,371,037 2,403,552
External sales [member] | Medical and wellness segments [member] | Alps Life Science Inc [Member]      
IfrsStatementLineItems [Line Items]      
Total revenue   3,353,006 2,390,113
External sales [member] | Life science segments [member] | Alps Life Science Inc [Member]      
IfrsStatementLineItems [Line Items]      
Total revenue   1,824 523
External sales [member] | All other segments [member] | Alps Life Science Inc [Member]      
IfrsStatementLineItems [Line Items]      
Total revenue   16,207 12,916
Inter segment sales [member] | Alps Life Science Inc [Member] | Elimination of intersegment amounts [member]      
IfrsStatementLineItems [Line Items]      
Total revenue   (736,233) (652,366)
Inter segment sales [member] | Alps Life Science Inc [Member] | Operating segments [member]      
IfrsStatementLineItems [Line Items]      
Total revenue  
Inter segment sales [member] | Medical and wellness segments [member] | Alps Life Science Inc [Member]      
IfrsStatementLineItems [Line Items]      
Total revenue   43,361 187,142
Inter segment sales [member] | Life science segments [member] | Alps Life Science Inc [Member]      
IfrsStatementLineItems [Line Items]      
Total revenue   611,666 392,896
Inter segment sales [member] | All other segments [member] | Alps Life Science Inc [Member]      
IfrsStatementLineItems [Line Items]      
Total revenue   $ 81,206 $ 72,328